RE:RE:Taimed raising money Trogarzo's market estimates were closer to a fantasy than reality now they also have competition for this small salvage group of patients. First line therapy is much bigger market, quartly or biannually long acting administered drugs will be far more easier sale. Both companies are disappointed with the drug's sales having said that if Taimed's drugs get approved thery will be far more appealing to patients.
LouisW wrote: If i remember correctly, they claimed they dont want to work with TH for their potential drug due to the disappointig sale of Trogarzo.